An interventional study of Adapted Cognitive Behavioral Intervention for Trauma in Schools (CBITS) with a Racial Trauma Module (RTM) in PTSD - Post Traumatic Stress Disorder and Substance Use, sponsored by University of California, San Francisco. Not yet recruiting at 1 site in United States. Open to participants aged 13 Years and older. Per ClinicalTrials.gov, last updated 2026-07-06.
Sponsored by University of California, San Francisco · Not applicable, Interventional, and Treatment
This pilot study, conducted in partnership with juvenile detention centers, evaluates an adapted CBITS-RTM intervention delivered in a detention school setting.
The study examines the intervention's feasibility and acceptability, as well as its effectiveness in reducing incarcerated youth's posttraumatic stress symptoms, improving academic functioning, and decreasing intentions to use substances post-release.
200 studies on the registry are indexed under Combat Disorders; 90 are open to participants now.
This study's planned enrollment of 28 is below the median of 72 across 167 interventional studies indexed under Combat Disorders.
Browse Combat Disorders studies →University of California, San Francisco is the lead sponsor of 2,169 studies on the registry; 372 are open to participants now.
Of its 267 completed or terminated interventional studies of FDA-regulated products, 202 (76%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Behavioral: Adapted Cognitive Behavioral Intervention for Trauma in Schools (CBITS) with a Racial Trauma Module (RTM)
The Cognitive Behavioral Intervention for Trauma in Schools (CBITS) program is a school-based, group and individual intervention designed to reduce symptoms of post-traumatic stress disorder (PTSD), depression, and behavioral problems, and to improve functioning, grades and attendance, and coping skills. The CBITS intervention was adapted to juvenile justice settings with an added Racial Trauma Module (RTM), which provides youth with an overview of the effects of racism on levels of traumatic stress.
Also known as: CBITS-RTM
Child PTSD Symptom Scale (CPSS)
The CPSS is used to measure posttraumatic stress among youth (8-18 years). It assesses past month posttraumatic stress symptom severity and impairment of endorsed symptoms on daily functioning. Scores range from 0-80, with 31+ indicating probable PTSD.
Time frame: Baseline, 3 months post-baseline
Youth Alcohol and Drug Use Survey
The Youth Alcohol and Drug Use Survey will be used to gather youth's intention to use substances post-release using items rated on a scale from 1 (unlikely) to 10 (very likely).
Time frame: Baseline, 3 months post-baseline
Texas Christian University (TCU) Drug Screen
The TCU will be administered to gather information on substance use quantity and frequency as well as risk for SUD (corresponds with DSM-5 criteria) on the 3-months prior to incarceration and past 3 months at post-release.
Time frame: Baseline, 3-months post-baseline
Youth Background Characteristics
Demographics questionnaire used to gather standard demographics (e.g., age, gender, race) and information such as state agency involvement (e.g., age at first contact with juvenile legal system, number of prior arrests), immigration status.
Time frame: Baseline
Treatment Acceptability Form
This form will be used to assess the acceptability of the adapted CBITS-RTM intervention. Items are scored from 1 "Strongly disagree" to 5 "Strongly agree." Scores range from 10-50 with higher scores indicating higher acceptability.
Time frame: 3-months post-baseline
CBITS-RTM Group Evaluation Posttest
This will assess knowledge of trauma, changes in ability to cope with stress, and acceptability of the intervention and its delivery. Items are true/false or qualitative in nature.
Time frame: 3-months post-baseline
Clinician personal and professional background characteristics
Questionnaire used to gather personal and professional background characteristics (e.g., clinical discipline, experience with trauma treatment, years of practice in juvenile detention setting).
Time frame: Baseline
Cognitive Behavioral Intervention for Trauma in Schools-Fidelity Adherence Measure 2.0
This measure will be used to assess how closely clinicians adhere to the adapted CBITS-RTM intervention. The scale describes the core components expected to be covered in each session, and the rater indicates the degree to which each component was delivered with fidelity using a 4-point item rating ranging from 0 (not covered at all) to 3 (covered thoroughly). Higher item scores indicate greater fidelity to the intervention curriculum.
Time frame: 20% of the sessions
The Evidence-Based Practice Attitude Scale (EBPAS)
The EBPAS (15-items) will be used to assess clinician's attitudes toward adopting new evidence-based practices (EBPs). It consists of four subscales: appeal, requirements, openness, and divergence. Items are rated on a 5-point Likert scale from 0 (not at all) to 4 (to a very great extent). Higher scores on the Appeal, Requirements, and Openness subscales indicate more positive attitudes toward adopting EBPs, whereas higher Divergence scores indicate less favorable attitudes.
Time frame: Baseline
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Sep 2026; primary completion for Jun 2027, 9 months later.
Of 73 non-industry interventional studies with no phase under Combat Disorders, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 44. This study's planned 9 months is below that.
Counting every sponsor, half of 79 studies reached it within 25 months; a quarter within 12 and three quarters within 44.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of California, San Francisco →